Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction
BACKGROUND--Lp(a) lipoprotein has structural homology with plasminogen and has been shown to inhibit plasminogen activation in vitro. OBJECTIVE--To determine whether the serum concentration of Lp(a) lipoprotein present when streptokinase was given in acute myocardial infarction influenced the outcom...
Gespeichert in:
| Veröffentlicht in: | British Heart Journal 1994-04, Vol.71 (4), p.316-321 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 321 |
|---|---|
| container_issue | 4 |
| container_start_page | 316 |
| container_title | British Heart Journal |
| container_volume | 71 |
| creator | MBewu, A. D. Durrington, P. N. Mackness, M. I. Hunt, L. Turkie, W. H. Creamer, J. E. |
| description | BACKGROUND--Lp(a) lipoprotein has structural homology with plasminogen and has been shown to inhibit plasminogen activation in vitro. OBJECTIVE--To determine whether the serum concentration of Lp(a) lipoprotein present when streptokinase was given in acute myocardial infarction influenced the outcome as judged by electrocardiographic methods. PATIENTS AND DESIGN--Serum Lp(a) lipoprotein concentration was measured in 135 consecutive patients admitted with a diagnosis of acute myocardial infarction who received streptokinase treatment. Recovery from myocardial injury was assessed by the reduction in the sum of ST segment elevation measured from the J point (STJ) in the electrocardiogram immediately before streptokinase was given compared with that three hours later. RESULTS--The serum Lp(a) lipoprotein concentrations were measured within 12 hours of the onset of symptoms of myocardial infarction and were higher than in healthy reference populations. Recovery from myocardial infarction could be assessed from the STJ in 116 patients (86% of the series). Those in whom it could not had bundle branch block, left ventricular hypertrophy, did not survive three hours, or had started intravenous nitrate treatment or some other clinical procedure before or at the time the second electrocardiogram was to be recorded. Patients with reductions in STJ after streptokinase that were > 4 mm (the median decrease) had mean (range) serum Lp(a) lipoprotein concentrations of 41.0 (0.8-220) mg/dl and those with a smaller reduction in STJ had concentrations of 29.1 (1.7-151) mg/dl. The difference was not statistically significant. CONCLUSION--In this study Lp(a) lipoprotein concentration did not significantly influence the outcome of thrombolytic treatment with streptokinase. |
| doi_str_mv | 10.1136/hrt.71.4.316 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_483679</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76524502</sourcerecordid><originalsourceid>FETCH-LOGICAL-b571t-51025057ff1228677ae52e69236da985cf95ccdbafb7b710cba11429fe0e300b3</originalsourceid><addsrcrecordid>eNp90c2L1DAYBvAgyjq7evMqBJRVwY5J2nz04EEGv2DQg-sHXkKaJk7GNqlJKs5_b5YOg3rwFMLze8MbHgDuYbTGuGbPdjGvOV436xqzG2CFGyYqgvCXm2CFEOIV4qy9Dc5T2pdr0wp2Bs4EboUQaAXMBxPnEW6nx-oJHNwUphiycR7q4LXxOarsgofK9zDMWYfRwGBh3sUwdmE4ZKdhjkblsVhoQ4TjIWgVe6cG6LxVUV_P3wG3rBqSuXs8L8DHVy-vNm-q7fvXbzcvtlVHOc4VxYhQRLm1mBDBOFeGEsNaUrNetYJq21Kt-07ZjnccI90pjBvSWoNMjVBXX4Dny7vT3I2mXz4wyCm6UcWDDMrJvxPvdvJb-CkbUTPelvnL43wMP2aTshxd0mYYlDdhTpIzShqKSIEP_oH7MEdf_iYx5wgxxkld1NNF6RhSisaeNsFIXncnS3eSY9nI0l3h9__c_oSPZZX84TFXSavBRuW1SyfWYMSQoIVVC3Mpm1-nWMXvkvGaU_nu00Z-3l41NRJEfi3-0eK7cf__BX8DuBG_5Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1770066723</pqid></control><display><type>article</type><title>Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>MBewu, A. D. ; Durrington, P. N. ; Mackness, M. I. ; Hunt, L. ; Turkie, W. H. ; Creamer, J. E.</creator><creatorcontrib>MBewu, A. D. ; Durrington, P. N. ; Mackness, M. I. ; Hunt, L. ; Turkie, W. H. ; Creamer, J. E.</creatorcontrib><description>BACKGROUND--Lp(a) lipoprotein has structural homology with plasminogen and has been shown to inhibit plasminogen activation in vitro. OBJECTIVE--To determine whether the serum concentration of Lp(a) lipoprotein present when streptokinase was given in acute myocardial infarction influenced the outcome as judged by electrocardiographic methods. PATIENTS AND DESIGN--Serum Lp(a) lipoprotein concentration was measured in 135 consecutive patients admitted with a diagnosis of acute myocardial infarction who received streptokinase treatment. Recovery from myocardial injury was assessed by the reduction in the sum of ST segment elevation measured from the J point (STJ) in the electrocardiogram immediately before streptokinase was given compared with that three hours later. RESULTS--The serum Lp(a) lipoprotein concentrations were measured within 12 hours of the onset of symptoms of myocardial infarction and were higher than in healthy reference populations. Recovery from myocardial infarction could be assessed from the STJ in 116 patients (86% of the series). Those in whom it could not had bundle branch block, left ventricular hypertrophy, did not survive three hours, or had started intravenous nitrate treatment or some other clinical procedure before or at the time the second electrocardiogram was to be recorded. Patients with reductions in STJ after streptokinase that were > 4 mm (the median decrease) had mean (range) serum Lp(a) lipoprotein concentrations of 41.0 (0.8-220) mg/dl and those with a smaller reduction in STJ had concentrations of 29.1 (1.7-151) mg/dl. The difference was not statistically significant. CONCLUSION--In this study Lp(a) lipoprotein concentration did not significantly influence the outcome of thrombolytic treatment with streptokinase.</description><identifier>ISSN: 0007-0769</identifier><identifier>ISSN: 1355-6037</identifier><identifier>EISSN: 1468-201X</identifier><identifier>EISSN: 2053-5864</identifier><identifier>DOI: 10.1136/hrt.71.4.316</identifier><identifier>PMID: 8198880</identifier><identifier>CODEN: BHJUAV</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Cardiovascular Society</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Blood. Blood coagulation. Reticuloendothelial system ; Coronary Angiography ; Electrocardiography ; Female ; Fibrinogen - analysis ; Heart - physiopathology ; Humans ; Lipoprotein(a) - blood ; Male ; Medical sciences ; Middle Aged ; Myocardial Infarction - blood ; Myocardial Infarction - diagnostic imaging ; Myocardial Infarction - drug therapy ; Myocardial Infarction - physiopathology ; Pharmacology. Drug treatments ; Streptokinase - therapeutic use ; Thrombolytic Therapy ; Time Factors ; Treatment Outcome</subject><ispartof>British Heart Journal, 1994-04, Vol.71 (4), p.316-321</ispartof><rights>1994 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD Apr 1994</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b571t-51025057ff1228677ae52e69236da985cf95ccdbafb7b710cba11429fe0e300b3</citedby><cites>FETCH-LOGICAL-b571t-51025057ff1228677ae52e69236da985cf95ccdbafb7b710cba11429fe0e300b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC483679/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC483679/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4106085$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8198880$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MBewu, A. D.</creatorcontrib><creatorcontrib>Durrington, P. N.</creatorcontrib><creatorcontrib>Mackness, M. I.</creatorcontrib><creatorcontrib>Hunt, L.</creatorcontrib><creatorcontrib>Turkie, W. H.</creatorcontrib><creatorcontrib>Creamer, J. E.</creatorcontrib><title>Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction</title><title>British Heart Journal</title><addtitle>Br Heart J</addtitle><description>BACKGROUND--Lp(a) lipoprotein has structural homology with plasminogen and has been shown to inhibit plasminogen activation in vitro. OBJECTIVE--To determine whether the serum concentration of Lp(a) lipoprotein present when streptokinase was given in acute myocardial infarction influenced the outcome as judged by electrocardiographic methods. PATIENTS AND DESIGN--Serum Lp(a) lipoprotein concentration was measured in 135 consecutive patients admitted with a diagnosis of acute myocardial infarction who received streptokinase treatment. Recovery from myocardial injury was assessed by the reduction in the sum of ST segment elevation measured from the J point (STJ) in the electrocardiogram immediately before streptokinase was given compared with that three hours later. RESULTS--The serum Lp(a) lipoprotein concentrations were measured within 12 hours of the onset of symptoms of myocardial infarction and were higher than in healthy reference populations. Recovery from myocardial infarction could be assessed from the STJ in 116 patients (86% of the series). Those in whom it could not had bundle branch block, left ventricular hypertrophy, did not survive three hours, or had started intravenous nitrate treatment or some other clinical procedure before or at the time the second electrocardiogram was to be recorded. Patients with reductions in STJ after streptokinase that were > 4 mm (the median decrease) had mean (range) serum Lp(a) lipoprotein concentrations of 41.0 (0.8-220) mg/dl and those with a smaller reduction in STJ had concentrations of 29.1 (1.7-151) mg/dl. The difference was not statistically significant. CONCLUSION--In this study Lp(a) lipoprotein concentration did not significantly influence the outcome of thrombolytic treatment with streptokinase.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Coronary Angiography</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Fibrinogen - analysis</subject><subject>Heart - physiopathology</subject><subject>Humans</subject><subject>Lipoprotein(a) - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - blood</subject><subject>Myocardial Infarction - diagnostic imaging</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Myocardial Infarction - physiopathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Streptokinase - therapeutic use</subject><subject>Thrombolytic Therapy</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0007-0769</issn><issn>1355-6037</issn><issn>1468-201X</issn><issn>2053-5864</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp90c2L1DAYBvAgyjq7evMqBJRVwY5J2nz04EEGv2DQg-sHXkKaJk7GNqlJKs5_b5YOg3rwFMLze8MbHgDuYbTGuGbPdjGvOV436xqzG2CFGyYqgvCXm2CFEOIV4qy9Dc5T2pdr0wp2Bs4EboUQaAXMBxPnEW6nx-oJHNwUphiycR7q4LXxOarsgofK9zDMWYfRwGBh3sUwdmE4ZKdhjkblsVhoQ4TjIWgVe6cG6LxVUV_P3wG3rBqSuXs8L8DHVy-vNm-q7fvXbzcvtlVHOc4VxYhQRLm1mBDBOFeGEsNaUrNetYJq21Kt-07ZjnccI90pjBvSWoNMjVBXX4Dny7vT3I2mXz4wyCm6UcWDDMrJvxPvdvJb-CkbUTPelvnL43wMP2aTshxd0mYYlDdhTpIzShqKSIEP_oH7MEdf_iYx5wgxxkld1NNF6RhSisaeNsFIXncnS3eSY9nI0l3h9__c_oSPZZX84TFXSavBRuW1SyfWYMSQoIVVC3Mpm1-nWMXvkvGaU_nu00Z-3l41NRJEfi3-0eK7cf__BX8DuBG_5Q</recordid><startdate>19940401</startdate><enddate>19940401</enddate><creator>MBewu, A. D.</creator><creator>Durrington, P. N.</creator><creator>Mackness, M. I.</creator><creator>Hunt, L.</creator><creator>Turkie, W. H.</creator><creator>Creamer, J. E.</creator><general>BMJ Publishing Group Ltd and British Cardiovascular Society</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19940401</creationdate><title>Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction</title><author>MBewu, A. D. ; Durrington, P. N. ; Mackness, M. I. ; Hunt, L. ; Turkie, W. H. ; Creamer, J. E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b571t-51025057ff1228677ae52e69236da985cf95ccdbafb7b710cba11429fe0e300b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Coronary Angiography</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Fibrinogen - analysis</topic><topic>Heart - physiopathology</topic><topic>Humans</topic><topic>Lipoprotein(a) - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - blood</topic><topic>Myocardial Infarction - diagnostic imaging</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Myocardial Infarction - physiopathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Streptokinase - therapeutic use</topic><topic>Thrombolytic Therapy</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MBewu, A. D.</creatorcontrib><creatorcontrib>Durrington, P. N.</creatorcontrib><creatorcontrib>Mackness, M. I.</creatorcontrib><creatorcontrib>Hunt, L.</creatorcontrib><creatorcontrib>Turkie, W. H.</creatorcontrib><creatorcontrib>Creamer, J. E.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British Heart Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MBewu, A. D.</au><au>Durrington, P. N.</au><au>Mackness, M. I.</au><au>Hunt, L.</au><au>Turkie, W. H.</au><au>Creamer, J. E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction</atitle><jtitle>British Heart Journal</jtitle><addtitle>Br Heart J</addtitle><date>1994-04-01</date><risdate>1994</risdate><volume>71</volume><issue>4</issue><spage>316</spage><epage>321</epage><pages>316-321</pages><issn>0007-0769</issn><issn>1355-6037</issn><eissn>1468-201X</eissn><eissn>2053-5864</eissn><coden>BHJUAV</coden><abstract>BACKGROUND--Lp(a) lipoprotein has structural homology with plasminogen and has been shown to inhibit plasminogen activation in vitro. OBJECTIVE--To determine whether the serum concentration of Lp(a) lipoprotein present when streptokinase was given in acute myocardial infarction influenced the outcome as judged by electrocardiographic methods. PATIENTS AND DESIGN--Serum Lp(a) lipoprotein concentration was measured in 135 consecutive patients admitted with a diagnosis of acute myocardial infarction who received streptokinase treatment. Recovery from myocardial injury was assessed by the reduction in the sum of ST segment elevation measured from the J point (STJ) in the electrocardiogram immediately before streptokinase was given compared with that three hours later. RESULTS--The serum Lp(a) lipoprotein concentrations were measured within 12 hours of the onset of symptoms of myocardial infarction and were higher than in healthy reference populations. Recovery from myocardial infarction could be assessed from the STJ in 116 patients (86% of the series). Those in whom it could not had bundle branch block, left ventricular hypertrophy, did not survive three hours, or had started intravenous nitrate treatment or some other clinical procedure before or at the time the second electrocardiogram was to be recorded. Patients with reductions in STJ after streptokinase that were > 4 mm (the median decrease) had mean (range) serum Lp(a) lipoprotein concentrations of 41.0 (0.8-220) mg/dl and those with a smaller reduction in STJ had concentrations of 29.1 (1.7-151) mg/dl. The difference was not statistically significant. CONCLUSION--In this study Lp(a) lipoprotein concentration did not significantly influence the outcome of thrombolytic treatment with streptokinase.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Cardiovascular Society</pub><pmid>8198880</pmid><doi>10.1136/hrt.71.4.316</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-0769 |
| ispartof | British Heart Journal, 1994-04, Vol.71 (4), p.316-321 |
| issn | 0007-0769 1355-6037 1468-201X 2053-5864 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_483679 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Adult Aged Aged, 80 and over Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Coronary Angiography Electrocardiography Female Fibrinogen - analysis Heart - physiopathology Humans Lipoprotein(a) - blood Male Medical sciences Middle Aged Myocardial Infarction - blood Myocardial Infarction - diagnostic imaging Myocardial Infarction - drug therapy Myocardial Infarction - physiopathology Pharmacology. Drug treatments Streptokinase - therapeutic use Thrombolytic Therapy Time Factors Treatment Outcome |
| title | Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A44%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20Lp(a)%20lipoprotein%20concentration%20and%20outcome%20of%20thrombolytic%20treatment%20for%20myocardial%20infarction&rft.jtitle=British%20Heart%20Journal&rft.au=MBewu,%20A.%20D.&rft.date=1994-04-01&rft.volume=71&rft.issue=4&rft.spage=316&rft.epage=321&rft.pages=316-321&rft.issn=0007-0769&rft.eissn=1468-201X&rft.coden=BHJUAV&rft_id=info:doi/10.1136/hrt.71.4.316&rft_dat=%3Cproquest_pubme%3E76524502%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1770066723&rft_id=info:pmid/8198880&rfr_iscdi=true |